Biotec

The BIOS Initiative - open source biotechnology is born

In a publication today in the prestigious scientific journal, Nature, a team at CAMBIA in Canberra unveils the 'kernel' of the world's first 'explicit open source' biotechnolog...

First production of human monoclonal antibodies in chicken eggs published in Nature Biotechnology

Chicken-produced antibodies demonstrate enhanced cell killing compared to conventionally produced anti-cancer antibodies Origen Therapeutics today announced the first published scientific report of fully functional, human sequence monoclonal antibodies (mAbs) produced in chickens. The antibodies were expressed solely in the chicken oviduct and deposited into egg white in concentrations of...

UC Davis researchers move biotechnology closer to replacing electronic pacemakers

UC Davis researchers have successfully used a custom designed protein and gene delivery system to restore normal heart rhythms in pigs with electronic pacemakers, reducing their dependence on implanted devices. This work suggests that scientists are one step closer to making bioengineering a reality in treating the more than 2.2 million Americans affected by irregular heartbeats. The UC...

MWG Biotech expands siMAX?siRNA portfolio with new scales, lengths and design tools

University of Utah researchers showed that a fruit fly gene is crucial for determining when juveniles begin to mature into adults, and how the transformation initially proceeds. Understanding this process in humans may help explain how adorable children become surly teenagers. When the DHR4 gene is disabled, fruit flies prematurely begin metamorphosis ?maturation from an immature larva to...

California computer scientists double volume of data in NIH biotech repository

Faster computation of haplotypes provides insight into genetic basis of human diseaseHigh-throughput sequencing of an individual's DNA yields a map of genetic variation which can give clues to the genetic underpinning of human disease. The current technologies collect genotypes, or information from the individual's two chromosomes. Yet many scientists believe that drilling down to the variation...

More>>

Biotec at Biology Products

Goat Anti-TGase3 (S-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.

Description:TGase3 (S-20)...
Company:Santa Cruz Biotechnology, Inc.

Goat Anti-SCCRO (S-17) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.

Description:SCCRO (S-17)...
Company:Santa Cruz Biotechnology, Inc.

Mouse Anti-Human S-100 alpha/beta chain Monoclonal Antibody, Unconjugated, Clone 8B10 from Santa Cruz Biotechnology, Inc.

Description:S-100 alpha/beta chain (8B10)...
Company:Santa Cruz Biotechnology, Inc.

Goat Anti-ZBP-89 (S-15) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.

Description:ZBP-89 (S-15)...
Company:Santa Cruz Biotechnology, Inc.

AAIBiotech Solutions from AAIPharma Inc.

Description:AAIPharmas Biotech Solutions Group combines deep experience, skills and flexibility in product development with special qualities of collaborative team chemistry. This combination enables optimum solutions and strategy from concept to approval and beyond.With AAIBiotech, you can count on our excellent scientific capabilities. But you get more than that: its the power of team chemistry that...
Company:AAIPharma Inc.

More>>

Biotec at Biology Technology

Wisconsin won't get Georgia biotech without a fight

And that's because Georgia is not simply willing to let go of , an Athens, Ga. business that produces neural stem cell kits for research...

The 10 biggest events shaping biotech in 2006

Here's my list, in order of importance: biofuels, stem cells, BIO 2006 in Chicago, the reshaping and resurgence of Abbott Labs, biogenerics in the U.S., the internationalizat...

Gala Biotech among companies sold for $3.3 billion

for $3.3 billio...

Biotech industry reaches midpoint in 50-year maturation cycle

An interesting article in ) on March 1 states unequivocally that most industry cycles run about 50 years until they mature. If this...

First graduates boon to Wisconsin biotechnology

MADISON - Two years ago, 10 students working as scientists, business managers and lawyers came together with a single goal: to become leaders in this state's burgeoning biotechnology industry. On Saturday, May 15, they will graduate as the first alumni of the at the University of Wisconsin-Madi...

More>>

Biotec at Biology Definition

Biotechnology

. Of the many different definit...

Biotec at Biology Dictionary

Biotechnology

...

Biotec at Medicine News

Biotechnology industry expected to grow into a three billion dollar industry by 2002

The biotech products market in India is expected to grow into a three billion dollar industry by 2002 according to a Rabo India finance report. The big leap is expected to triple the industry's size from its 1999 value of one billion dollars. Biogenerics, biopharmaceuticals, agriculture, food and nutrition sectors are all poised for the big leap, both nationally and internationally. Th...

Biotechnology on the lead

Public health experts have stated that Biotechnology will provide the most effective defence against bioterrorism. The completion of the human genome project, and developments in understanding of diseases like anthrax and botulism, will help in developing tests and vaccines that will protect society against bioterrorist attacks - as well as natural epidemics.// The annual meeting of t...

Panacea Biotech To Market Anthrax Vaccine

Panacea Biotech has bagged the registration, production and marketing rights of the anti-anthrax vaccine developed by the Centre for Biotechnology in the Jawaharlal Nehru University (JNU). It is expected that the vaccine would be in the market in 3-4 months. The Company has made a milestone payment to JNU for the exclusive rights. In addition, it will pay the university a royalty on sales. Howeve...

Commercialization of Biotech Discoveries, An Encouragement For Researchers

The Central government of India plans to come out with a legislation to pave the way for commercialisation of technologies discovery by Indian universities //and research institutions to create a strong domestic biotech industry. The proposed legislation would give Indian universities and institutions such as the Indian Council of Medical Research and CSIR the ability to stake claims on...

Biotech drug causing anemia-EPREX

EPREX, a version of the human recombinant "erythropoietin", a genetically engineered drug, has recently been found to cause a potentially life-threatening anaemia among patients who have been administered with this drug. This drug introduced in the late 1980s and is used to treat patients with kidney disease. //The disease, called Pure Red Cell Aphasia or PRCA usually occurs in vanishingly small...

More>>

Biotec at Medicine Products

Cambridge Biotech HIV-1 (Western Blot)

Description:Non-Donor Supplemental: Calypte Biomedical Corporation sells the only FDA-approved urine-based HIV-1 antibody testing algorithm as well as the serum-based Cambridge Biotech HIV-1 Western Blot Kit [Human Immunodeficiency Virus Type 1 (HIV-1)]. Grouped together, Calypte products represent a portfolio of established and cutting-edge tests and testing services have been created to serve the ever-cha...
Company:Calypte Biomedical Corp

TRINITY BIOTECH UNI-GOLD H. PYLORI TEST

Description:The Trinity Biotech Uni-Gold™ H. pylori assay is intended for the rapid, in vitro qualitative detection of IgG antibodies to Helicobacter pylori (H. pylori) in adult human serum, plasma or whole blood as an aid in the diagnosis of H. pylori infection in patients with clinical signs and symptoms of gastrointestinal disease....
Company:Trinity Biotech

Trinity Biotech Captia™ B. burgdorferi IgG/IgM ELISA

Description:The Trinity Biotech Captia Borrelia burgdorferi (B. burgdorferi) IgG/IgM Enzyme Linked Immunosorbent Assay (ELISA) is intended for the qualitative presumptive (firststep) detection of total (IgG/IgM) antibodies to Borrelia burgdorferi in human serum. This ELISA should only be used for patients with signs and symptoms that are consistent with Lyme disease. Equivocal or positive results must be sup...
Company:Trinity Biotech

Biotec at Medicine Technology

Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology

WORCESTER, Mass., Jun 27, 2007 (PrimeNewswire via COMTEX NewsNetwork) -- Generex Biotechnology Corporation (Nasdaq:GNBT), theleader in drug delivery for metabolic diseases through the innerlining of the mouth, announced today that it will be making threeposter presentations at the 46th Annual Meeting of the EuropeanSociety of Pediatric Endocrinology in Helsinki, Finland June 27 --30, 200...

Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference

LOS ANGELES--(BUSINESS WIRE)--July 8, 2007 - Cougar Biotechnology,Inc. (OTCBB:CGRB) today announced that positive Phase I and PhaseII data on the Company's prostate cancer drug candidate CB7630(abiraterone acetate) were presented at the European Society forMedical Oncology (ESMO) Conference, which is currently taking placein Lugano, Switzerland. The data were presented in two oral andposter...

Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis

SCHLIEREN (Zurich), Switzerland, July 3, 2007 - Cytos BiotechnologyAG (SWX:CYTN) announced today results from a phase IIa study withCYT003-QbG10 in atopic dermatitis. CYT003-QbG10 is animmunotherapeutic product candidate currently in development forthe treatment of allergic diseases. The present study aimed toassess safety, tolerability and exploratory efficacy of the productcandidate in a...

Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease

Adult stem cells cultivated from patients' own blood canpotentially improve the quality of life for patients whose lowerextremities are affected by peripheral vascular disease, accordingto a study in China. SHENZHEN, China, July 02, 2007 /PRNewswire/ -- BeikeBiotechnology Co., Ltd. (<a target="_blank" href="http://www.beikebiotech.com/">http://www.beikebiotech.com )today announced tha...

Biotec Pharmacon Announces Preliminary Results from the Sloan-Kettering Clinical Study

TROMSØ, Norway, June 29, 2007-Preliminary results fromthe immunotherapeutic cancer study at Memorial Sloan-KetteringCancer Center show a very good safety profile for SBG. Furthermore,encouraging responses on cancer development have been observedamong several patients that have been treated with SBG incombination with the monoclonal antibody against neuroblastoma. In line wit...

More>>